A genetic framework for improving arrhythmia therapy

Nature

Volumn 451, Issue 7181, 2008, Pages 929-936

  Knollmann, Björn C ^a   Roden, Dan M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NEUROLEPTIC AGENT; POTASSIUM CHANNEL BLOCKING AGENT; SODIUM CHANNEL BLOCKING AGENT; SPIDER VENOM;

DISEASE TREATMENT; GENETIC ANALYSIS; MOLECULAR ANALYSIS; MORTALITY;

DEATH; DEFIBRILLATOR; DISEASE PREDISPOSITION; DRUG HYPERSENSITIVITY; GASTROINTESTINAL DISEASE; GENETIC DISORDER; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE FAILURE; HEART RHYTHM; HEART VENTRICLE CONTRACTILITY; HUMAN; NONHUMAN; PATIENT IDENTIFICATION; POPULATION GENETICS; PRIORITY JOURNAL; REVIEW; RISK;

EID: 39749149703     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature06799     Document Type: Review

References (100)